Robert Wasserman

2.4k total citations
35 papers, 1.8k citations indexed

About

Robert Wasserman is a scholar working on Immunology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Robert Wasserman has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Public Health, Environmental and Occupational Health and 12 papers in Molecular Biology. Recurrent topics in Robert Wasserman's work include Acute Lymphoblastic Leukemia research (13 papers), T-cell and B-cell Immunology (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Robert Wasserman is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), T-cell and B-cell Immunology (9 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Robert Wasserman collaborates with scholars based in United States, Spain and Canada. Robert Wasserman's co-authors include Richard R. Hardy, G Rovera, B A Reichard, S Shane, Kyoko Hayakawa, Masao Yamada, A J Caton, Beverly J. Lange, Richard B. Womer and Naomi Galili and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Robert Wasserman

32 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert Wasserman 945 545 537 462 344 35 1.8k
HA Messner 516 0.5× 561 1.0× 1.3k 2.4× 327 0.7× 396 1.2× 53 2.1k
MR Loken 725 0.8× 493 0.9× 1.1k 2.0× 161 0.3× 266 0.8× 13 1.8k
R. Foà 1.1k 1.2× 493 0.9× 617 1.1× 397 0.9× 475 1.4× 65 2.3k
F Coral 697 0.7× 361 0.7× 895 1.7× 329 0.7× 847 2.5× 22 2.3k
Marion Baudard 312 0.3× 541 1.0× 686 1.3× 191 0.4× 369 1.1× 34 1.3k
Andries C. Bloem 709 0.8× 706 1.3× 792 1.5× 78 0.2× 628 1.8× 57 1.9k
Paulo Vidal Campregher 950 1.0× 323 0.6× 429 0.8× 106 0.2× 569 1.7× 57 1.7k
Mark Klinger 872 0.9× 504 0.9× 274 0.5× 145 0.3× 696 2.0× 30 1.7k
Anne Tierens 572 0.6× 504 0.9× 590 1.1× 174 0.4× 778 2.3× 101 2.2k
Anna Guarini 1.4k 1.5× 441 0.8× 652 1.2× 454 1.0× 853 2.5× 90 2.6k

Countries citing papers authored by Robert Wasserman

Since Specialization
Citations

This map shows the geographic impact of Robert Wasserman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wasserman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wasserman more than expected).

Fields of papers citing papers by Robert Wasserman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Wasserman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wasserman. The network helps show where Robert Wasserman may publish in the future.

Co-authorship network of co-authors of Robert Wasserman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Wasserman. A scholar is included among the top collaborators of Robert Wasserman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Wasserman. Robert Wasserman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bendell, Johanna C., James Strauss, Marwan Fakih, et al.. (2020). Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8/CKB pathway, in patients with advanced gastrointestinal (GI) solid tumors.. Journal of Clinical Oncology. 38(15_suppl). 3504–3504. 1 indexed citations
3.
Sinclair, Angus M., Robin Hallett, Patricia Giblin, et al.. (2018). Abstract 1751: MSC-1 is a first-in-class humanized monoclonal antibody that modulates the tumor microenvironment by inhibiting a novel cancer immunotherapy target, LIF. Cancer Research. 78(13_Supplement). 1751–1751. 1 indexed citations
4.
Hardwick, James S., Yi Yang, Chunsheng Zhang, et al.. (2005). Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling. Molecular Cancer Therapeutics. 4(3). 413–425. 24 indexed citations
5.
Rheingold, Susan R., et al.. (2002). Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemia.. PubMed. 62(15). 4212–6. 7 indexed citations
6.
Hardy, Richard R., et al.. (2000). Response by B Cell Precursors to Pre-B Receptor Assembly: Differences Between Fetal Liver and Bone Marrow. Current topics in microbiology and immunology. 252. 25–30. 8 indexed citations
7.
Wasserman, Robert, Susan A. Shinton, Condie E. Carmack, et al.. (1998). A Novel Mechanism for B Cell Repertoire Maturation Based on Response by B Cell Precursors to Pre–B Receptor Assembly. The Journal of Experimental Medicine. 187(2). 259–264. 99 indexed citations
8.
Finger, L R, Jeffrey J. Pu, Robert Wasserman, et al.. (1997). The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene. 197(1-2). 177–187. 92 indexed citations
9.
Hayakawa, Kyoko, et al.. (1997). B Lymphocyte Developmental Lineages. Annals of the New York Academy of Sciences. 815(1). 15–28. 23 indexed citations
10.
Wasserman, Robert, et al.. (1997). Down-regulation of terminal deoxynucleotidyl transferase by Ig heavy chain in B lineage cells. The Journal of Immunology. 158(3). 1133–1138. 49 indexed citations
11.
Wasserman, Robert, et al.. (1996). Identification of the Earliest B Lineage Stage in Mouse Bone Marrow. Immunity. 5(6). 527–535. 308 indexed citations
12.
Wasserman, Robert, et al.. (1995). Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. The Journal of Immunology. 155(2). 644–651. 40 indexed citations
13.
Wasserman, Robert, Naomi Galili, B A Reichard, et al.. (1993). Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia.. Journal of Clinical Oncology. 11(3). 546–553. 45 indexed citations
14.
Wasserman, Robert, Yoshiaki Ito, Naomi Galili, et al.. (1992). The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stage. The Journal of Immunology. 149(2). 511–516. 28 indexed citations
15.
Wasserman, Robert, Naomi Galili, Yoshiaki Ito, et al.. (1992). Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event.. The Journal of Experimental Medicine. 176(6). 1577–1581. 65 indexed citations
16.
Wasserman, Robert, Naomi Galili, Jeffrey H. Silber, et al.. (1992). Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.. Journal of Clinical Oncology. 10(12). 1879–1888. 80 indexed citations
17.
Yamada, Masao, Robert Wasserman, B A Reichard, et al.. (1991). Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes.. The Journal of Experimental Medicine. 173(2). 395–407. 333 indexed citations
18.
Yamada, Masao, Robert Wasserman, Beverly J. Lange, et al.. (1990). Minimal Residual Disease in Childhood B-Lineage Lymphoblastic Leukemia. New England Journal of Medicine. 323(7). 448–455. 163 indexed citations
19.
D’Angio, Giulio J., Audrey E. Evans, & Robert Wasserman. (1989). Fibrosarcoma in a child with neurofibromatosis. Medical and Pediatric Oncology. 17(4). 271–273. 1 indexed citations
20.
Chiorazzi, Nicholas, Robert Wasserman, & Henry G. Kunkel. (1982). Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.. The Journal of Experimental Medicine. 156(3). 930–935. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by HA Messner Breakdown of academic impact, for papers by MR Loken Breakdown of academic impact, for papers by R. Foà Breakdown of academic impact, for papers by F Coral Breakdown of academic impact, for papers by Marion Baudard Breakdown of academic impact, for papers by Andries C. Bloem Breakdown of academic impact, for papers by Paulo Vidal Campregher Breakdown of academic impact, for papers by Mark Klinger Breakdown of academic impact, for papers by Anne Tierens Breakdown of academic impact, for papers by Anna Guarini
Rankless by CCL
2026